These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16162695)

  • 1. Regular vs ad-lib albuterol for patients hospitalized with acute asthma.
    Chandra A; Shim C; Cohen HW; Chung V; Maggiore D; Mani K; Dhuper S
    Chest; 2005 Sep; 128(3):1115-20. PubMed ID: 16162695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department.
    Rodrigo GJ; Rodrigo C
    Am J Respir Crit Care Med; 2000 Jun; 161(6):1862-8. PubMed ID: 10852758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency treatment of acute asthma with albuterol metered-dose inhaler plus holding chamber: how often should treatments be administered?
    Karpel JP; Aldrich TK; Prezant DJ; Guguchev K; Gaitan-Salas A; Pathiparti R
    Chest; 1997 Aug; 112(2):348-56. PubMed ID: 9266868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.
    Israel E; Chinchilli VM; Ford JG; Boushey HA; Cherniack R; Craig TJ; Deykin A; Fagan JK; Fahy JV; Fish J; Kraft M; Kunselman SJ; Lazarus SC; Lemanske RF; Liggett SB; Martin RJ; Mitra N; Peters SP; Silverman E; Sorkness CA; Szefler SJ; Wechsler ME; Weiss ST; Drazen JM;
    Lancet; 2004 Oct 23-29; 364(9444):1505-12. PubMed ID: 15500895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.
    Nowak R; Emerman C; Hanrahan JP; Parsey MV; Hanania NA; Claus R; Schaefer K; Baumgartner RA;
    Am J Emerg Med; 2006 May; 24(3):259-67. PubMed ID: 16635694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network.
    Drazen JM; Israel E; Boushey HA; Chinchilli VM; Fahy JV; Fish JE; Lazarus SC; Lemanske RF; Martin RJ; Peters SP; Sorkness C; Szefler SJ
    N Engl J Med; 1996 Sep; 335(12):841-7. PubMed ID: 8778601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
    Rowe BH; Wong E; Blitz S; Diner B; Mackey D; Ross S; Senthilselvan A
    Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. As-required versus regular nebulized salbutamol for the treatment of acute severe asthma.
    Bradding P; Rushby I; Scullion J; Morgan MD
    Eur Respir J; 1999 Feb; 13(2):290-4. PubMed ID: 10065670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
    Pearlman DS; Chervinsky P; LaForce C; Seltzer JM; Southern DL; Kemp JP; Dockhorn RJ; Grossman J; Liddle RF; Yancey SW
    N Engl J Med; 1992 Nov; 327(20):1420-5. PubMed ID: 1357554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled study to evaluate the role of salmeterol in the in-hospital management of asthma.
    Peters JI; Shelledy DC; Jones AP; Lawson RW; Davis CP; LeGrand TS
    Chest; 2000 Aug; 118(2):313-20. PubMed ID: 10936118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework.
    Dennis SM; Sharp SJ; Vickers MR; Frost CD; Crompton GK; Barnes PJ; Lee TH
    Lancet; 2000 May; 355(9216):1675-9. PubMed ID: 10905242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
    Gappa M; Zachgo W; von Berg A; Kamin W; Stern-Sträter C; Steinkamp G;
    Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma.
    Bijl-Hofland ID; Cloosterman SG; Folgering HT; van den Elshout FJ; van Weel C; van Schayck CP
    Am J Respir Crit Care Med; 2001 Sep; 164(5):764-9. PubMed ID: 11549530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.